Your browser doesn't support javascript.
loading
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Clingan, Philip; Ladwa, Rahul; Brungs, Daniel; Harris, Dean Laurence; McGrath, Margaret; Arnold, Susan; Coward, Jermaine; Fourie, Samuel; Kurochkin, Andriy; Malan, Daniel R; Mant, Andrew; Sharma, Vinay; Shue, Hong; Tazbirkova, Andrea; Berciano-Guerrero, Miguel-Angel; Charoentum, Chaiyut; Dalle, Stéphane; Dechaphunkul, Arunee; Dudnichenko, Oleksandr; Koralewski, Piotr; Lugowska, Iwona; Montaudié, Henri; Muñoz-Couselo, Eva; Sriuranpong, Virote; Oliviero, James; Desai, Jayesh.
Afiliación
  • Clingan P; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia.
  • Ladwa R; Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.
  • Brungs D; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia.
  • Harris DL; Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
  • McGrath M; Christchurch Hospital, Christchurch, New Zealand.
  • Arnold S; Medical Oncology, Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, Queensland, Australia.
  • Coward J; Exellentis Clinical Trial Consultants, George, South Africa.
  • Fourie S; ICON Cancer Centre, South Brisbane, Queensland, Australia.
  • Kurochkin A; Wilgers Oncology Centre, Pretoria, South Africa.
  • Malan DR; Municipal Nonprofit Enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Dispensary, Sumy, Ukraine.
  • Mant A; Phoenix Pharma, Port Elizabeth, South Africa.
  • Sharma V; Medical Oncology Unit, Eastern Health, Melbourne, Victoria, Australia.
  • Shue H; Wits Clinical Research Chris Hani Baragwanath Clinical Trial Site, Johannesburg, South Africa.
  • Tazbirkova A; Sunshine Coast Haematology and Oncology Clinic, Buderim, Queensland, Australia.
  • Berciano-Guerrero MA; Medical Oncology, Pindara Private Hospital, Gold Coast, Queensland, Australia.
  • Charoentum C; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
  • Dalle S; Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand.
  • Dechaphunkul A; Hospices Civils de Lyon - Hopital Lyon Sud, Pierre-Bénite, France.
  • Dudnichenko O; Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand.
  • Koralewski P; Kharkiv Medical Academy of Postgraduate Education, Chair of Oncology and Children's Oncology, Clinical base State institution "VT Zaycev Institute of General and Urgent Surgery of National Academy Medical Sciences of Ukraine", Kharkiv, Ukraine.
  • Lugowska I; Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Sp. z o.o., Oddzial Onkologii Klinicznej z Pododdzialem Dziennym, Kraków, Poland.
  • Montaudié H; Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Oddzial Badan Wczesnych Faz, Warsaw, Poland.
  • Muñoz-Couselo E; Centre Hospitalier Universitaire de Nice - Hôpital l'Archet, Nice, France.
  • Sriuranpong V; Hospital Universitario Vall d'Hebron, Passeig de la Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Oliviero J; King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Desai J; Checkpoint Therapeutics Inc, Waltham, Massachusetts, USA jfo@checkpointtx.com.
J Immunother Cancer ; 11(10)2023 10.
Article en En | MEDLINE | ID: mdl-37848259
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células Escamosas Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células Escamosas Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido